Many have asked me how Moderna, a dedicated mRNA company, could make such a bad product out of the gate as their first market entry? Much of the answer relates to a development blunder made by Moderna scientists dating back many years.
Moderna’s Great Immunological Blunder
Written by Peter A. McCullough, MD, MPH